Contact: Sarah Avery
Duke University Medical Center
Caption: Researchers at Duke Medicine have solved some of the mysteries related to the use of aspirin, and developed a blood-based test of gene activity that has been shown to accurately identify who will respond to the therapy and who is at higher risk for heart attack.
Credit: Duke Medicine
Usage Restrictions: None
Related news release: Biomarker predicts heart attack risk based on response to aspirin therapy